| Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||
|---|---|---|---|---|---|---|
|
fig.2.e
Carron C et al. (2005) |
Xla Wt + igf1
NF10.5 (in situ hybridization) |
|
|||
|
fig.5.n
Carron C et al. (2005) |
Xla Wt + igf1
NF37/38 (in situ hybridization) |
|
|||
|
|
fig.2.f
Carron C et al. (2005) |
Xla Wt + otx2
NF10.5 (in situ hybridization) |
|
|||
|
fig.4.i
Carron C et al. (2005) |
Xla Wt + otx2-VP16
NF10.5 (in situ hybridization) |
|
|||
|
|
fig.4.h
Carron C et al. (2005) |
Xla Wt + dnigf1r
NF10.5 (in situ hybridization) |
|